Danaher Corporation (DHR) Holdings Trimmed by Bbva Compass Bancshares Inc.
Bbva Compass Bancshares Inc. lowered its holdings in shares of Danaher Corporation (NYSE:DHR) by 5.9% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,860 shares of the conglomerate’s stock after selling 875 shares during the period. Bbva Compass Bancshares Inc.’s holdings in Danaher Corporation were worth $1,189,000 as of its most recent SEC filing.
A number of other institutional investors have also made changes to their positions in the business. BlackRock Inc. increased its position in shares of Danaher Corporation by 2,530.9% during the 1st quarter. BlackRock Inc. now owns 37,967,922 shares of the conglomerate’s stock valued at $3,247,398,000 after purchasing an additional 36,524,795 shares during the period. Flossbach Von Storch AG increased its position in shares of Danaher Corporation by 44.7% during the 2nd quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the conglomerate’s stock valued at $487,945,000 after purchasing an additional 1,785,810 shares during the period. Vanguard Group Inc. increased its position in shares of Danaher Corporation by 3.9% during the 1st quarter. Vanguard Group Inc. now owns 40,967,631 shares of the conglomerate’s stock valued at $3,503,962,000 after purchasing an additional 1,530,015 shares during the period. Arrowstreet Capital Limited Partnership increased its position in shares of Danaher Corporation by 16,410.0% during the 2nd quarter. Arrowstreet Capital Limited Partnership now owns 1,485,901 shares of the conglomerate’s stock valued at $125,395,000 after purchasing an additional 1,476,901 shares during the period. Finally, Koch Industries Inc. increased its position in shares of Danaher Corporation by 29,127.3% during the 2nd quarter. Koch Industries Inc. now owns 1,404,665 shares of the conglomerate’s stock valued at $1,388,000 after purchasing an additional 1,399,859 shares during the period. 75.38% of the stock is currently owned by hedge funds and other institutional investors.
In other Danaher Corporation news, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the business’s stock in a transaction dated Wednesday, November 1st. The stock was sold at an average price of $92.64, for a total value of $11,671,620.96. Following the completion of the sale, the chief executive officer now owns 271,737 shares of the company’s stock, valued at $25,173,715.68. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, SVP Daniel Raskas sold 37,870 shares of the business’s stock in a transaction dated Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. In the last three months, insiders have sold 317,498 shares of company stock valued at $28,838,801. Insiders own 12.20% of the company’s stock.
Danaher Corporation (DHR) opened at $93.30 on Friday. Danaher Corporation has a twelve month low of $76.27 and a twelve month high of $93.86. The company has a current ratio of 1.43, a quick ratio of 1.00 and a debt-to-equity ratio of 0.42. The firm has a market capitalization of $65,090.00, a price-to-earnings ratio of 23.96, a PEG ratio of 2.22 and a beta of 1.02.
Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.95 by $0.05. The firm had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The business’s revenue for the quarter was up 9.6% on a year-over-year basis. During the same quarter last year, the firm earned $0.87 earnings per share. analysts expect that Danaher Corporation will post 3.99 EPS for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were given a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, September 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.60%. Danaher Corporation’s payout ratio is 16.67%.
TRADEMARK VIOLATION NOTICE: This news story was originally reported by Daily Political and is owned by of Daily Political. If you are reading this news story on another website, it was stolen and reposted in violation of international copyright laws. The correct version of this news story can be read at https://www.dailypolitical.com/2017/11/18/danaher-corporation-dhr-holdings-trimmed-by-bbva-compass-bancshares-inc.html.
Several equities analysts have recently issued reports on the company. Robert W. Baird lifted their price target on Danaher Corporation from $87.00 to $97.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Credit Suisse Group lifted their price target on Danaher Corporation from $93.00 to $96.00 and gave the company an “outperform” rating in a research report on Friday, October 20th. Morgan Stanley lifted their price target on Danaher Corporation from $95.00 to $98.00 and gave the company an “overweight” rating in a research report on Friday, October 20th. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research report on Thursday, October 5th. Finally, Cowen and Company reiterated a “buy” rating and set a $90.00 price target on shares of Danaher Corporation in a research report on Wednesday, October 4th. One equities research analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the company’s stock. The company presently has a consensus rating of “Buy” and a consensus target price of $93.31.
Danaher Corporation Company Profile
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR).
Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.